Tonix Pharmaceuticals Holding (TNXP) Debt Ratio (2010 - 2024)
Tonix Pharmaceuticals Holding (TNXP) posted Debt Ratio of 0.07 for Q4 2024, down 16.31% on a QoQ basis from 0.08 in Q3 2024, and down 18.53% year-over-year from 0.09 in Q1 2024.
Powered by 
Analysis
Tonix Pharmaceuticals Holding (TNXP) Debt Ratio (2010 - 2024) Analysis & Trends
Tonix Pharmaceuticals Holding has reported Debt Ratio for 6 years, with the latest figure at 0.07 in Q4 2024.
- On a quarterly basis, Debt Ratio fell 18.53% year-over-year to 0.07 in Q4 2024; TTM through Dec 2024 was 0.07, a 18.53% decrease from a year earlier, with the FY2024 full-year figure at 0.07, down 18.53% from the prior year.
- Debt Ratio was 0.07 for Q4 2024 at Tonix Pharmaceuticals Holding, down from 0.08 in the prior quarter.
- The five-year high for Debt Ratio was 0.12 in Q2 2024, with the low at 0.07 in Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 0.30 |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 0.08 |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 0.31 |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 0.17 |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | 0.12 |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 0.00 |
| 10 | Tonix Pharmaceuticals Holding | 220.65 Mn | 220.65 Mn | 12.84 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 0.07 |
| Sep 30, 2024 | 0.08 |
| Jun 30, 2024 | 0.12 |
| Mar 31, 2024 | 0.07 |
| Dec 31, 2023 | 0.09 |
| Jun 30, 2014 | 0.01 |
| Mar 31, 2014 | 0.01 |
| Dec 31, 2013 | 0.03 |
| Sep 30, 2013 | 0.04 |
| Dec 31, 2011 | 0.35 |
| Sep 30, 2011 | 48.78 |
| Jun 30, 2011 | 13.39 |
| Dec 31, 2010 | 0.05 |